For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Kursk 305035

0 studies enrolling now · 8 studies all time

What they study most

Diabetes Mellitus, Type 2, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Non Small Cell Lung Cancer, Rheumatoid Arthritis, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer — Running, not enrolling
• A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer — Completed
• A Study of LY900014 in Participants With Type 1 Diabetes — Completed
• A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes — Completed
• An Open Label Study for Participants With Rheumatoid Arthritis — Stopped early
• A Study in Participants With Rheumatoid Arthritis — Stopped early
• A Rheumatoid Arthritis Study in Participants — Completed
• A Study in Patients With Type 2 Diabetes Mellitus — Completed